CDAX-GESAMTINDEX (PERF)/ DE0008469602
CDAX2024-04-19 5:50:00 PM | Chg. -9.07 | Open | High | Low | Previous Close |
---|---|---|---|---|---|
1,527.32XXP | -0.59% | 1,536.38 | 1,536.38 | 1,519.14 | 1,536.39 |
GlobeNewswire
2017-01-12
Hawesko Holding AG: Hawesko Group strengthens positioning in fine wine segment with ultra-premium sp...
GlobeNewswire
2016-12-13
MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or...
GlobeNewswire
2016-12-06
MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 201...
GlobeNewswire
2016-12-06
MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016
GlobeNewswire
2016-11-29
MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...
GlobeNewswire
2016-11-28
MorphoSys Announces That Its Licensee Janssen Has Submitted a Marketing Authorisation Application Fo...
GlobeNewswire
2016-11-25
MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...
GlobeNewswire
2016-11-22
Correction of a release from 21.11.2016, 18:05 CET - MorphoSys AG: Publication pursuant to §26 sect....
GlobeNewswire
2016-11-21
MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...
GlobeNewswire
2016-11-21
MorphoSys AG: Notification of managers`transactions according to article 19 MAR
GlobeNewswire
2016-11-21
MorphoSys AG: Notification of managers`transactions according to article 19 MAR
GlobeNewswire
2016-11-17
MorphoSys Announces That Its Licensee Janssen Has Submitted Biologics License Application For Guselk...
GlobeNewswire
2016-11-17
MorphoSys AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of...
GlobeNewswire
2016-11-15
MorphoSys Announces That Its Licensee Janssen Has Presented Positive Clinical Data of Guselkumab in ...
GlobeNewswire
2016-11-14
Hawesko Holding AG: Raimund Hackenberger will become the new chief financial officer
GlobeNewswire
2016-11-08
Anke Linnartz joins MorphoSys as Head of Corporate Communications and Investor Relations